SCHEMBL8726206

SCHEMBL8726206

NC(=O)CC[C@H](NC(=O)Nc1ccc(N(CCCl)CCCl)cc1)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.51
LMNA P02545 2/20 0.49
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
FOLH1 Q04609 6/20 0.47
JAK2 O60674 1/20 0.47
FPR2 P25090 1/20 0.46
HDAC1 Q13547 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
CYP3A4 P08684 3/20 0.45
ALDH1A1 P00352 2/20 0.45
ALOX15 P16050 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
HIF1A Q16665 2/20 0.45
ABCB11 O95342 1/20 0.45
CHRM2 P08172 1/20 0.45
ADRA2A P08913 1/20 0.45
CHRM1 P11229 1/20 0.45
ACHE P22303 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7902186 0.90 FOLH1 (0.58) KMT2ALMNAFOLH1FPR2HDAC1
SCHEMBL4458797 0.90 FOLH1 (0.58) KMT2ALMNAFOLH1FPR2HDAC1
Hydrochloric Acid SCHEMBL7903946 0.89 FOLH1 (0.57) KMT2ALMNAFOLH1FPR2HDAC1
SCHEMBL8723910 0.84 KMT2A (0.42) KMT2ALMNACA1CA2FOLH1
SCHEMBL8727524 0.82 KMT2A (0.67) KMT2ALMNACA1CA2HDAC2
SCHEMBL8721907 0.81 LMNA (0.47) KMT2ALMNACA1CA2JAK2
SCHEMBL20334999 0.81 KMT2A (0.74) KMT2ACA1CA2FOLH1JAK2
SCHEMBL20334998 0.81 KMT2A (0.74) KMT2ACA1CA2FOLH1JAK2
Trifluoroacetic Acid SCHEMBL29966022 0.81 LMNA (0.46) KMT2ALMNACA1CA2HDAC1
SCHEMBL20335123 0.80 KMT2A (0.58) KMT2ALMNACA1CA2FOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0651740-B1 AMINO ACID LINKED NITROGEN MUSTARD DERIVATIVES AND THEIR USE AS PRODRUGS IN THE TREATMENT OF TUMOURS ZENECA LTD (GB) 1998-10-21 EP claimed